SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (2190)8/29/2017 6:58:08 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3559
 
And again today (70 K shares): secfilings.nasdaq.com

Does ability to reach 30% cumulative holding terminate with termination of the antibody research agreement, or was extended as long as IO R&D contract is in place? Anyone with thought (knowledge)?